Carnevale, J. et al. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature 609, 174–182 (2022).Thank you for reading this post, don’t forget to subscribe! Article ADS CAS PubMed PubMed Central Google Scholar Freitas, K. A. et al. Enhanced T cell effector activity by targeting the Mediator kinase module. Science 378, eabn5647
Carnevale, J. et al. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature 609, 174–182 (2022).
Thank you for reading this post, don't forget to subscribe!Google Scholar
Freitas, K. A. et al. Enhanced T cell effector activity by targeting the Mediator kinase module. Science 378, eabn5647 (2022).
Google Scholar
Brudno, J. N., Maus, M. V. & Hinrichs, C. S. CAR T cells and T-cell therapies for cancer: a translational science review. JAMA 332, 1924–1935 (2024).
Google Scholar
Du, B. et al. CAR-T therapy in solid tumors. Cancer Cell 43, 665–679 (2025).
Google Scholar
Anderson, K. G., Stromnes, I. M. & Greenberg, P. D. Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies. Cancer Cell 31, 311–325 (2017).
Google Scholar
Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421–433 (2023).
Google Scholar
Shifrut, E. et al. Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function. Cell 175, 1958–1971.e15 (2018).
Google Scholar
Belk, J. A. et al. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell 40, 768–786.e7 (2022).
Google Scholar
Knudsen, N. H. et al. In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma. Nature 646, 953–962 (2025).
Google Scholar
Datlinger, P. et al. Systematic discovery of CRISPR-boosted CAR T cell immunotherapies. Nature 646, 963–972 (2025).
Google Scholar
Wei, J. et al. Targeting Regnase-1 programs long-lived effector T cells for cancer therapy. Nature 576, 471–476 (2019).
Google Scholar
Siska, P. J. et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2, e93411 (2017).
Google Scholar
Klysz, D. D. et al. Inosine induces stemness features in CAR-T cells and enhances potency. Cancer Cell 42, 266–282.e8 (2024).
Google Scholar
Sutra Del Galy, A. et al. In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response. Sci. Immunol. 6, eabe8219 (2021).
Google Scholar
Si, J. et al. Hematopoietic progenitor kinase 1 (HPK1) mediates T cell dysfunction and is a druggable target for T cell-based immunotherapies. Cancer Cell 38, 551–566.e11 (2020).
Google Scholar
Morotti, M. et al. PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function. Nature 629, 426–434 (2024).
Google Scholar
Luo, C. et al. Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells. Immunity 58, 745–765.e9 (2025).
Google Scholar
Lacher, S. B. et al. PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells. Nature 629, 417–425 (2024).
Google Scholar
Wang, B. & Bian, Q. SATB1 prevents immune cell infiltration by regulating chromatin organization and gene expression of a chemokine gene cluster in T cells. Commun. Biol. 7, 1304 (2024).
Google Scholar
Verdeil, G. MAF drives CD8+ T-cell exhaustion. Oncoimmunology 5, e1082707 (2016).
Google Scholar
Kim, Y. J. et al. The transcription factor Mef2d regulates B:T synapse-dependent GC-TF differentiation and IL-21-mediated humoral immunity. Sci. Immunol. 8, eadf2248 (2023).
Google Scholar
Giordano, M. et al. The tumor necrosis factor α-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proc. Natl Acad. Sci. USA 111, 11115–11120 (2014).
Google Scholar
Szeto, A. C. H. et al. Mef2d potentiates type-2 immune responses and allergic lung inflammation. Science 384, eadl0370 (2024).
Google Scholar
Dahabieh, M. S. et al. The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8+ T cell exhaustion. Nat. Immunol. 26, 1139–1151 (2025).
Google Scholar
Pham, T. H., Okada, T., Matloubian, M., Lo, C. G. & Cyster, J. G. S1P1 receptor signaling overrides retention mediated by Gαi-coupled receptors to promote T cell egress. Immunity 28, 122–133 (2008).
Google Scholar
Arnon, T. I. et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333, 1898–1903 (2011).
Google Scholar
Muppidi, J. R., Lu, E. & Cyster, J. G. The G protein-coupled receptor P2RY8 and follicular dendritic cells promote germinal center confinement of B cells, whereas S1PR3 can contribute to their dissemination. J. Exp. Med. 212, 2213–2222 (2015).
Google Scholar
Muppidi, J. R. et al. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature 516, 254–258 (2014).
Google Scholar
Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212–20217 (2013).
Google Scholar
McCandless, E. E., Zhang, B., Diamond, M. S. & Klein, R. S. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl Acad. Sci. USA 105, 11270–11275 (2008).
Google Scholar
Kabashima, K. et al. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9, 744–749 (2003).
Google Scholar
Lu, E., Wolfreys, F. D., Muppidi, J. R., Xu, Y. & Cyster, J. G. S-geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. Nature 567, 244–248 (2019).
Google Scholar
Gallman, A. E. et al. Abcc1 and Ggt5 support lymphocyte guidance through export and catabolism of S-geranylgeranyl-l-glutathione. Sci. Immunol. 6, eabg1101 (2021).
Google Scholar
Jung, I. Y. et al. CRISPR/Cas9-mediated knockout of DGK improves antitumor activities of human T cells. Cancer Res. 78, 4692–4703 (2018).
Google Scholar
Wang, H. et al. Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells. Int. Immunopharmacol. 147, 113971 (2025).
Google Scholar
Schmidt, R. et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science 375, eabj4008 (2022).
Google Scholar
Postler, T. S. A most versatile kinase: the catalytic subunit of PKA in T-cell biology. Int. Rev. Cell Mol. Biol. 361, 301–318 (2021).
Google Scholar
Zhang, M. et al. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct. Target. Ther. 9, 88 (2024).
Google Scholar
Wu, V. H. et al. The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure. Nat. Immunol. 24, 1318–1330 (2023).
Google Scholar
Ben Nasr, M. et al. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule. Cell Metab. 36, 1302–1319.e12 (2024).
Google Scholar
Zeng, S. et al. Local TSH/TSHR signaling promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma. Cancer Commun. 44, 1287–1310 (2024).
Google Scholar
Giuffrida, L. et al. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy. Nat. Commun. 12, 3236 (2021).
Google Scholar
Li, S. et al. In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions. Front. Immunol. 15, 1483258 (2024).
Google Scholar
Qiao, G. et al. β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol. Immunother. 68, 11–22 (2019).
Google Scholar
Nehama, D. et al. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres. EBioMedicine 47, 33–43 (2019).
Google Scholar
Vitanza, N. A. et al. Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial. Nat. Med. 31, 861–868 (2025).
Google Scholar
Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029–1045.e5 (2018).
Google Scholar
Qi, C. et al. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results. Nat. Med. 28, 1189–1198 (2022).
Google Scholar
Goudy, L. et al. Integrated epigenetic and genetic programming of primary human T cells. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02856-w (2025).
Barnkob, M. B. et al. Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells. Nat. Commun. 15, 3173 (2024).
Google Scholar
Matas-Rico, E. et al. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells. Cell Rep. 37, 110013 (2021).
Google Scholar
Carlson, C. R. et al. Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J. Biol. Chem. 281, 21535–21545 (2006).
Google Scholar
Newick, K. et al. Augmentation of CAR T-cell trafficking and antitumor efficacy by blocking protein kinase A localization. Cancer Immunol. Res. 4, 541–551 (2016).
Google Scholar
Wunderlich, M. et al. Improved multilineage human hematopoietic reconstitution and function in NSGS mice. PLoS ONE 13, e0209034 (2018).
Google Scholar
Shindyapin, V. V. et al. Myeloid cell mobilization and recruitment by human mesothelioma in NSG-SGM3 mice. Cells 13, 2135 (2024).
Google Scholar
Billerbeck, E. et al. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγnull humanized mice. Blood 117, 3076–3086 (2011).
Google Scholar
Zorn, J. A. et al. Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model. Sci. Rep. 12, 3530 (2022).
Google Scholar
Siegler, E. L. et al. Efficient gene editing of CART cells with CRISPR-Cas12a for enhanced antitumor efficacy. Blood 136, 6–7 (2020).
Google Scholar
Tieu, V. et al. A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells. Cell 187, 1278–1295.e20 (2024).
Google Scholar
Takacsi-Nagy, O. et al. Evolutionarily guided transcription factor design programs novel T cell states. Preprint at bioRxiv https://doi.org/10.1101/2024.11.06.622344 (2024).
Keep following us for the latest insights.
